TCRX

Q: What is the price of Tscan Therapeutics Inc (TCRX) today?

The price of Tscan Therapeutics Inc (TCRX) today is $ 1.01, with return of -19.84% compared to the last year. The price of Tscan Therapeutics Inc (TCRX) started the year trading around $ 1.02 and today it is at $ 1.01. Follow the real-time price chart, the historical price of Tscan Therapeutics Inc (TCRX) and international markets.

Q: When does Tscan Therapeutics Inc (TCRX) pay dividends?

Tscan Therapeutics Inc (TCRX) did not distribute dividends in the last year.

Q: Is Tscan Therapeutics Inc (TCRX) worth it?

Currently, Tscan Therapeutics Inc (TCRX) is priced at $ 1.01, with a P/E of -1.01%, representing a deviation of -165% from its historical average P/E. In the last year, the stock showed a variation of -19.84 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -19.84%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Tscan Therapeutics Inc (TCRX) stock?

Investing in stocks of Tscan Therapeutics Inc (TCRX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Tscan Therapeutics Inc (TCRX) yield today?

The yield of Tscan Therapeutics Inc (TCRX) was -9.82% in the last month, -19.84% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Tscan Therapeutics Inc (TCRX) today, the total investment would be $ 101.00, based on the current price of $ 1.01.If past performance were to repeat, the return on your investment would be:In 1 year: $ 80.96In 5 years: $ 101.00In 10 years: $ 101.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Tscan Therapeutics Inc

Price

$ 1.01

return (12m)

-19.84%

p/e

-1.01

p/bv

1.07

DIVIDEND YIELD

0.00%

TCRX price

TCRX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment TCRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-9.82%

3 months

-2.88%

1 year

-19.84%

2 years

-85.75%

5 years

0.00%

10 years

0.00%

Fundamentals TCRX

review the fundamentals of Tscan Therapeutics Inc shares

P/E

-1.01

Sector: 6.67 Industry: 6.67

P/S (PSR)

12.70

Sector: 2.03 Industry: 2.03

P/BV

1.07

Sector: 1.80 Industry: 1.80

DIVIDEND YIELD (DY)

0.00%

Sector: 0.68% Industry: 0.68%

ROA

-56.72%

Sector: -0.76% Industry: -0.76%

ROE

-105.40%

Sector: 2.95% Industry: 2.95%

ROIC

Sector: -73.96% Industry: -73.96%

NET MARGIN

-100.00%

Sector: 1.24% Industry: 1.24%

GROSS MARGIN

85.57%

Sector: 30.00% Industry: 30.00%

OPERATING MARGIN

-100.00%

Sector: 3.32% Industry: 3.32%

EV/EBITDA

-0.97

Sector: 1.24 Industry: 1.24

EV/EBIT

-0.95

Sector: -0.98 Industry: -0.98

PRICE-TO-ASSETS

0.57

Sector: 0.87 Industry: 0.87

BVPS

0.95

Sector: 8.99 Industry: 8.99

EPS

-1.00

Sector: 0.59 Industry: 0.59

EQUITY-TO-ASSETS RATIO

0.54

Sector: 0.40 Industry: 0.40

LIABILITIES / ASSETS

0.46

Sector: 0.49 Industry: 0.49

CAGR REVENUE 5 YEARS

0.36%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

21.69%

Sector: - Industry: -

Fundamentals TCRX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
META	23.98	6.67	27.83%	0.37%	$ 1.45 T	30.08%
INTR	14.51	1.81	12.49%	1.44%	$ 3.45 B	15.62%
PBR	6.59	1.74	26.37%	5.80%	$ 132.49 B	22.13%
VALE	29.39	2.01	6.85%	6.26%	$ 69.12 B	6.12%
PLTR	218.07	47.33	21.70%	0.00%	$ 354.37 B	36.31%
SHEL	15.26	1.55	10.17%	3.11%	$ 272.13 B	6.68%
BDORY	10.67	0.75	6.98%	2.48%	$ 26.43 B	9.30%
MAIN	9.60	1.58	16.48%	7.52%	$ 4.74 B	83.37%
ENB	21.95	2.50	11.38%	5.03%	$ 118.05 B	11.49%
NSRGY	10.76	6.07	56.41%	3.47%	$ 251.79 B	10.91%
PBR-A	5.98	1.58	26.37%	5.77%	$ 120.25 B	22.13%
ITUB	12.01	2.47	20.61%	2.92%	$ 97.55 B	27.17%
UNH	20.84	2.47	11.85%	3.19%	$ 251.20 B	2.69%
BBSEY	8.18	7.03	85.85%	11.65%	$ 13.37 B	100.00%
SAN	11.08	1.36	12.24%	1.85%	$ 178.94 B	23.74%
TTE	15.61	1.74	11.17%	6.98%	$ 204.92 B	7.20%
RACE	32.92	0.00	0.00%	0.92%	$ 60.18 B	22.35%
TD	10.20	1.75	17.19%	3.17%	$ 159.97 B	34.54%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

TCRX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Tscan Therapeutics Inc

Tscan Therapeutics Inc

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

The Company Tscan Therapeutics Inc (United States), is listed on Nasdaq with a market value of $ 131.16 Millions, having an equity of $ 123.12 Millions.

The Company is listedthe in the sector of Others and categorized in industry of Others.

In the last 12 months the Company had a revenue of $ 10.33 Millions, which generated a loss in the amount of $ -129.77 Millions.

As for its main indicators, the Company has a P/E ratio of -1.01, a P/BV ratio of 1.07 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker TCRX.

Market cap

$ 131.16 Millions

Net worth

$ 123.12 Millions

US$ 123,123,000.00

Assets

$ 228.79 Millions

US$ 228,789,000.00

Total Shares Outstanding

129.86 Millions

129,862,000

Average Daily Trading Volume

$ 831.00 Thousand

US$ 830,998.00

Sector

Others

Industry

Others

TCRX

TCRX revenue and profits

Financial Results TCRX

DRAG THE FRAME TO SEE MORE DATA

TCRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

SHG - Shinhan Financial Group Co Ltd

$ 62.16 109,82% (12M)

P/E

0.01

2.38%

ROE

0.00%

P/BV

0.00

ALIZY - Allianz SE ADR

$ 42.42 28,44% (12M)

P/E

1.65

4.02%

ROE

69.03%

P/BV

1.14

CRERF - Carrefour SA

$ 18.40 37,90% (12M)

P/E

2.81

6.97%

ROE

12.16%

P/BV

0.34

UNH - UnitedHealth Group Incorporated

$ 277.26 --45,70% (12M)

P/E

20.84

3.19%

ROE

11.85%

P/BV

2.47

STLA - Stellantis NV

$ 7.55 --16,01% (12M)

P/E

-1.08

9.46%

ROE

-32.04%

P/BV

0.34

COR - Cencora Inc.

$ 324.80 17,51% (12M)

P/E

38.77

0.71%

ROE

77.54%

P/BV

30.06

BLSH - Bullish

$ 36.37 --47,89% (12M)

P/E

-7.18

0.00%

ROE

-23.69%

P/BV

1.70

SHEL - Shell PLC ADR

$ 93.10 51,00% (12M)

P/E

15.26

3.11%

ROE

10.17%

P/BV

1.55